CA2166313A1 - Reactifs pour l'hepatite non-a, non-b, non-c, non-d et procede pour leur utilisation - Google Patents

Reactifs pour l'hepatite non-a, non-b, non-c, non-d et procede pour leur utilisation

Info

Publication number
CA2166313A1
CA2166313A1 CA002166313A CA2166313A CA2166313A1 CA 2166313 A1 CA2166313 A1 CA 2166313A1 CA 002166313 A CA002166313 A CA 002166313A CA 2166313 A CA2166313 A CA 2166313A CA 2166313 A1 CA2166313 A1 CA 2166313A1
Authority
CA
Canada
Prior art keywords
hgbv
sequence
amino acid
acid sequence
genome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002166313A
Other languages
English (en)
Inventor
John N. Simons
Tami J. Pilot-Matias
George J. Dawson
George G. Schlauder
Suresh M. Desai
Thomas P. Leary
Anthony Scott Muerhoff
James Carl Erker
Sheri L. Buijk
Isa K. Mushahwar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2166313A1 publication Critical patent/CA2166313A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Séquences d'acide nucléique et d'acides aminés du virus de l'hépatite GB (VHGB) utiles pour diverses applications dans le diagnostic et le traitement, kits pour la mise en oeuvre des séquences d'acides nucléiques et d'acides aminés du VHGB, particules immunogènes du VHGB et anticorps se liant spécifiquement au VHGB. L'invention décrit également des procédés pour la production d'anticorps polyclonaux ou monoclonaux à partir des séquences d'acides nucléiques ou d'acides aminés du VHGB.
CA002166313A 1994-02-14 1995-02-14 Reactifs pour l'hepatite non-a, non-b, non-c, non-d et procede pour leur utilisation Abandoned CA2166313A1 (fr)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US19603094A 1994-02-14 1994-02-14
US08/196,030 1994-02-14
US24265494A 1994-05-13 1994-05-13
US08/242,654 1994-05-13
US28331494A 1994-07-29 1994-07-29
US08/283,314 1994-07-29
US34419094A 1994-11-23 1994-11-23
US34418594A 1994-11-23 1994-11-23
US08/344,190 1994-11-23
US08/344,185 1994-11-23
US34455795A 1995-01-27 1995-01-27
US08/344,557 1995-01-27

Publications (1)

Publication Number Publication Date
CA2166313A1 true CA2166313A1 (fr) 1995-08-17

Family

ID=27558868

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002166313A Abandoned CA2166313A1 (fr) 1994-02-14 1995-02-14 Reactifs pour l'hepatite non-a, non-b, non-c, non-d et procede pour leur utilisation

Country Status (2)

Country Link
CA (1) CA2166313A1 (fr)
WO (1) WO1995021922A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859230A (en) * 1992-07-30 1999-01-12 Genelabs Technologies, Inc. Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
US5981172A (en) * 1994-02-14 1999-11-09 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
US6156495A (en) * 1994-02-14 2000-12-05 Abbott Laboratories Hepatitis GB virus recombinant proteins and uses thereof
US5874563A (en) * 1994-05-20 1999-02-23 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
WO1995032290A2 (fr) * 1994-05-20 1995-11-30 Genelabs Technologies, Inc. Agents de l'hepatite non a/non b/non c/non d/non e et leur clonage moleculaire
WO1995032291A2 (fr) * 1994-05-20 1995-11-30 Genelabs Technologies, Inc. Virus de l'hepatite g et son clonage moleculaire
US5824507A (en) * 1994-05-20 1998-10-20 Genelabs Technologies, Inc. Hepatitis G virus and molecular cloning thereof
WO1998029747A1 (fr) * 1994-11-23 1998-07-09 Abbott Laboratories Reactifs et procedes permettant de detecter un antigene du virus de l'hepatite gb
US5709997A (en) * 1995-08-14 1998-01-20 Abbott Laboratories Nucleic acid detection of hepatitis GB virus
US5807670A (en) * 1995-08-14 1998-09-15 Abbott Laboratories Detection of hepatitis GB virus genotypes
IT1283893B1 (it) * 1996-01-24 1998-05-07 Sorin Biomedica Diagnostics Sp Metodo per rilevare sequenze nucleotidiche di virus associati a epatiti nona-none, peptidi e composizioni
DE19613406A1 (de) * 1996-04-03 1997-10-09 Boehringer Mannheim Gmbh Expression von HGV-Antigenen und deren Verwendung
DE69735364T3 (de) * 1996-05-24 2010-05-06 Biogen Idec Ma Inc., Cambridge Modulatoren für die regenerierung von gewebe
WO1999058561A1 (fr) * 1998-05-14 1999-11-18 Pasteur Merieux Serums & Vaccins Mimotopes du virus de l'hepatite c
US6541616B1 (en) 1998-10-01 2003-04-01 Antex Biologics Inc. Moraxella catarrhalis protein, gene sequence and uses thereof
GB9912432D0 (en) * 1999-05-27 1999-07-28 Angeletti P Ist Richerche Bio Novel gbv sequence
US7129342B1 (en) 1999-06-04 2006-10-31 The United States Of America As Represented By The Department Of Health And Human Services Infectious cDNA clone of GB virus B and uses thereof
EP1185665B1 (fr) * 1999-06-04 2008-09-10 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Clone infectieux d'adnc du gb virus-b et ses utilisations

Also Published As

Publication number Publication date
WO1995021922A3 (fr) 2001-09-13
WO1995021922A2 (fr) 1995-08-17

Similar Documents

Publication Publication Date Title
CA2065287C (fr) Isolats hvc nouveaux
US5871903A (en) HCV isolates
KR0185373B1 (ko) Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
CA2166313A1 (fr) Reactifs pour l'hepatite non-a, non-b, non-c, non-d et procede pour leur utilisation
US6051374A (en) Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
IE83377B1 (en) New HCV isolate J-1
JPH08509201A (ja) Ｅ型肝炎ウィルスワクチン及びその接種方法
WO1994018217A1 (fr) Reactifs des hepatites non-a, non-b, non-c, non-d, non-e et leurs procedes d'utilisation
KR0178399B1 (ko) 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프
JPH10503642A (ja) Ｇ型肝炎ウイルスおよびその分子クローニング
US5981172A (en) Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
EP0747482A2 (fr) Protéines récombinantes de virus de l'hépatite GB et leur utilisations
US6451578B1 (en) Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
WO1995032290A2 (fr) Agents de l'hepatite non a/non b/non c/non d/non e et leur clonage moleculaire
US6720166B2 (en) Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
US6586568B1 (en) Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
JP3848663B2 (ja) 非ａ非ｂ非ｃ非ｄ非ｅ型肝炎試薬及びそれらの使用方法
US6558898B1 (en) Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
EP0745129B1 (fr) Reactifs pour l'hepatite non-a, non-b, non-c, non-d et procede pour leur utilisation
AU640920C (en) Nanbv diagnostics and vaccines
WO2003068810A1 (fr) Sequence d'adn et polypeptide code utiles dans le diagnostic de la maladie hepatique
IL143675A (en) Polynucleotide capable of hybridizing to a complement of a genomic sequence of hepatitis c virus, polynucleotide probe comprising said polynucleotide and methods using said probe
LV10306B (en) Nanbv diagnostics and vaccines

Legal Events

Date Code Title Description
FZDE Discontinued